Morgan Wynes, PharmD, provides clinical pharmacy services for inpatient pediatric hematology/oncology patients and participates in multidisciplinary rounds at Hasbro Children’s. He serves on the oncology subcommittee and on a committee to develop and review evidence-based, standardized chemotherapy order sets.
Education: University of Rhode Island (PharmD, 2018; MBA 2018)
Residencies: PGY-1 Pharmacy Residency, University Hospitals, Portage Medical Center (2019); PGY-2 Pediatric Pharmacy Residency, Univerity of Wisconsin Health and American Family Children's Hospital (2020)
Practice/Research Interests: Pediatric ALL and neuroblastoma, oncologic supportive care, pediatric diabetes
Pronouns: He/him
Select Publications:
Wynes M, Boyle J. Effect of average blood glucose greater than 140 mg/dL on adverse patient outcomes in adult medical/surgical patients. Innov Pharm. 2021; 12 (1). doi:10.24926/iip.v12i1.3577.